Company Overview Izea, Inc. (NASDAQ: IZEA) operates an online marketplace that matches marketers (brands, advertising agencies, and publishers) with c...
SNAP, Inc., Muted Q3 Performance Detailed, and Plans for a Turnaround, Analysts Revisions
Snap Inc. (NYSE: SNAP) engages in the operation of its camera platform that helps people to communicate through short videos and images. The company i...
Globus Maritime, Dry Bulk Shipping Rates Could Recover by Mid-2018, Market Outlook
Company Description Globus Maritime Limited (NASDAQ: GLBS) is a dry bulk shipping company. The company provides international marine transportation se...
Auris Medical, Clinical Updates and Potential Catalysts
Auris Medical Holding AG (NASDAQ: EARS) is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical...
Capricor, CAP-1002 Updates with the FDA, Analysts Target Price and Pipeline Review
Capricor Therapeutics Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of fi...
Iovance, Earnings Review, Analysts Target Price and Upcoming SITC Data Release
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is focused on the development and commercialization of autologous cellular immunotherapies optimizing per...
Monster Digital, NASDAQ Listing Issues, Innovate Merger, and Product Review
Monster Digital (NASDAQ: MSDI) develops, markets, and distributes Monster-branded products for use in high-performance consumer electronics, mobile pr...
Calithera Biosciences, Q3 Analysis, Analysts Target and Clinical Trials Review
Calithera Biosciences, Inc. (NASDAQ: CALA) is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs...
Curis, Upcoming SITC Meeting, Aurigene Collaboration and Analysts Review
Curis, Inc. (NASDAQ: CRIS) is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for...
Keryx Biopharma, Auryxia Presentations, Upcoming PDUFA Date and Analysts Review
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), with headquarters in Boston, Massachusetts, is a commercial-stage company focused on bringing innovativ...